{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:47:55Z","timestamp":1793828875019,"version":"4.6.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068635"],"award-info":[{"award-number":["UM1AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068618"],"award-info":[{"award-number":["UM1AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029382","name":"HIV Vaccine Trials Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ebiom.2025.106017","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:35:22Z","timestamp":1763332522000},"page":"106017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-3881","authenticated-orcid":false,"given":"Valentin","family":"Voillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-0713","authenticated-orcid":false,"given":"Janine","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"One B.","family":"Dintwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pattacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faatima Laher","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Khuzwayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelda","family":"Euler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Schwedhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh R.","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fiore-Gartland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Juliana","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Stieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-920X","authenticated-orcid":false,"given":"Erica","family":"Andersen-Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.106017_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijid.2020.09.011","article-title":"Ending the epidemic of HIV\/AIDS by 2030: will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?","volume":"100","author":"Assefa","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6179","key":"10.1016\/j.ebiom.2025.106017_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1250672","article-title":"Immunology. Immune activation with HIV vaccines","volume":"344","author":"Fauci","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106017_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 7","key":"10.1016\/j.ebiom.2025.106017_bib4","article-title":"Current approaches to HIV vaccine development: a narrative review","volume":"24","author":"Kim","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106017_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/QAD.0b013e3283391d40","article-title":"HIV viral set point and host immune control in individuals with HIV-specific CD8+ T-cell responses prior to HIV acquisition","volume":"24","author":"Kaul","year":"2010","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106017_bib6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106017_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007054","article-title":"The T-cell response to HIV","volume":"2","author":"Walker","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106017_bib8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/infdis\/jit322","article-title":"Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection","volume":"208","author":"Janes","year":"2013","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106017_bib9","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2352-3018(20)30229-0","article-title":"Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1\/2a study","volume":"7","author":"Baden","year":"2020","journal-title":"Lancet HIV"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106017_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021225","article-title":"A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)","volume":"6","author":"Churchyard","year":"2011","journal-title":"PLoS One"},{"issue":"9653","key":"10.1016\/j.ebiom.2025.106017_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106017_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013579","article-title":"Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)","volume":"5","author":"Peiperl","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106017_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/infdis\/jiac445","article-title":"Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-uninfected adults: a phase 1\/2a study","volume":"227","author":"Stieh","year":"2023","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106017_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01126-23","article-title":"Mosaic HIV-1 vaccination induces anti-viral CD8(+) T cell functionality in the phase 1\/2a clinical trial APPROACH","volume":"97","author":"van Duijn","year":"2023","journal-title":"J Virol"},{"issue":"10143","key":"10.1016\/j.ebiom.2025.106017_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(18)31364-3","article-title":"Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1\/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)","volume":"392","author":"Barouch","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106017_bib16","article-title":"Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo\/HVTN 705\/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"25","author":"Gray","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2025.106017_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105320","article-title":"Immune correlates analysis of the Imbokodo (HVTN 705\/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study","volume":"108","author":"Kenny","year":"2024","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106017_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106017_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106017_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giaa127","article-title":"GigaSOM.jl: high-performance clustering and visualization of huge cytometry datasets","volume":"9","author":"Kratochvil","year":"2020","journal-title":"Gigascience"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/biostatistics\/kxt024","article-title":"Mixture models for single-cell assays with applications to vaccine studies","volume":"15","author":"Finak","year":"2014","journal-title":"Biostatistics"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib23","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","article-title":"From Louvain to Leiden: guaranteeing well-connected communities","volume":"9","author":"Traag","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ebiom.2025.106017_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-61737-950-5_8","article-title":"Multiparameter intracellular cytokine staining","volume":"699","author":"Lovelace","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106017_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/cyto.a.23331","article-title":"OMIP-044: 28-color immunophenotyping of the human dendritic cell compartment","volume":"93","author":"Mair","year":"2018","journal-title":"Cytometry A"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106017_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cyto.a.24350","article-title":"Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre","volume":"101","author":"Ashhurst","year":"2022","journal-title":"Cytometry A"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13059-019-1917-7","article-title":"A comparison framework and guideline of clustering methods for mass cytometry data","volume":"20","author":"Liu","year":"2019","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106017_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac260","article-title":"Analysis of the HIV vaccine trials network 702 phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk","volume":"226","author":"Moodie","year":"2022","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-017-0325-0","article-title":"Case-control matching: effects, misconceptions, and recommendations","volume":"33","author":"Mansournia","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"7549","key":"10.1016\/j.ebiom.2025.106017_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjsports-2023-107599","article-title":"Methods matter: (mostly) avoid categorising continuous data \u2013 a practical guide","volume":"58","author":"Binney","year":"2024","journal-title":"Br J Sports Med"},{"issue":"10427","key":"10.1016\/j.ebiom.2025.106017_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(24)00139-9","article-title":"Recommendations for accurate reporting in medical research statistics","volume":"403","author":"Mansournia","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106017_bib35","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/QAD.0000000000000314","article-title":"Programmed death-1 expression on CD4(+) and CD8(+) T cells in treated and untreated HIV disease","volume":"28","author":"Cockerham","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106017_bib36","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","article-title":"Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction","volume":"179","author":"D'Souza","year":"2007","journal-title":"J Immunol"},{"issue":"7109","key":"10.1016\/j.ebiom.2025.106017_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAD.0000000000002406","article-title":"T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy","volume":"34","author":"Macatangay","year":"2020","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106017_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144767","article-title":"Selective loss of early differentiated, highly functional PD1high CD4 T cells with HIV progression","volume":"10","author":"Paris","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib40","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1073\/pnas.94.5.1925","article-title":"The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes","volume":"94","author":"Bleul","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2025.106017_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104271","article-title":"Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: a meta-analysis of 26 vaccine regimens","volume":"84","author":"Huang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2025.106017_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101842","article-title":"Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS","volume":"70","author":"Nehar-Belaid","year":"2023","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106017_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving vaccine-induced immunity: can baseline predict outcome?","volume":"41","author":"Tsang","year":"2020","journal-title":"Trends Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106017_bib44","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1172\/JCI75429","article-title":"Immune activation alters cellular and humoral responses to yellow fever 17D vaccine","volume":"124","author":"Muyanja","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-024-00818-y","article-title":"Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report","volume":"9","author":"Maciel","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"19","key":"10.1016\/j.ebiom.2025.106017_bib46","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1128\/JVI.00056-12","article-title":"HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term","volume":"86","author":"Vingert","year":"2012","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.ebiom.2025.106017_bib47","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1128\/JVI.00228-07","article-title":"Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106017_bib48","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.1128\/JVI.00980-10","article-title":"HIV controllers with HLA-DRB1\u221713 and HLA-DQB1\u221706 alleles have strong, polyfunctional mucosal CD4+ T-cell responses","volume":"84","author":"Ferre","year":"2010","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106017_bib49","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/COH.0b013e32830ab9ee","article-title":"Mucosal immunity to HIV: a review of recent literature","volume":"3","author":"Shacklett","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib51","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/cr.2012.19","article-title":"Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China","volume":"22","author":"Jia","year":"2012","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106017_bib52","first-page":"519","article-title":"T-Cell subsets (T(CM), T(EM), T(EMRA)) and poly-functional immune response in patients with Human Immunodeficiency Virus (HIV) infection and different T-CD4 cell response","volume":"49","author":"Meraviglia","year":"2019","journal-title":"Ann Clin Lab Sci"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106017_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8(+) T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106017_bib54","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106017_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003038","article-title":"Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: a randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120\/MF59 vaccines","volume":"17","author":"Laher","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAD.0000000000000508","article-title":"Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection","volume":"29","author":"Radebe","year":"2015","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib57","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","article-title":"Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression","volume":"178","author":"Sacha","year":"2007","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106017_bib58","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1128\/JVI.00865-13","article-title":"Early Gag immunodominance of the HIV-specific T-cell response during acute\/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment","volume":"87","author":"Turk","year":"2013","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106017_bib59","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41467-021-22375-x","article-title":"Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells","volume":"12","author":"Rhodes","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106017_bib60","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41564-023-01349-3","article-title":"Monocyte-derived macrophages contain persistent latent HIV reservoirs","volume":"8","author":"Veenhuis","year":"2023","journal-title":"Nat Microbiol"},{"issue":"8028","key":"10.1016\/j.ebiom.2025.106017_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41586-024-07789-z","article-title":"Immune system adaptation during gender-affirming testosterone treatment","volume":"633","author":"Lakshmikanth","year":"2024","journal-title":"Nature"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500461X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500461X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:27:24Z","timestamp":1773332844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500461X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":61,"alternative-id":["S235239642500461X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106017","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106017"}}